RANDAL J KIRK Insider Trading $SNGX SOLIGENIX, INC.
Get free email notifications about insider trading for RANDAL J KIRK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is Director in CLINICAL DATA INC ($NOVI) and 10% Owner in AmpliPhi Biosciences Corp ($APHB) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in SOLIGENIX, INC. ($DOR) and 10% Owner in Synthetic Biologics, Inc. ($SYN) and 10% Owner in TRANSGENOMIC INC ($TBIO) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and 10% Owner in ORAGENICS INC ($OGEN) and 10% Owner in INTREXON CORP ($XON) and Chief Executive Officer in INTREXON CORP ($XON) and Director in INTREXON CORP ($XON) and Executive Chairman in INTREXON CORP ($XON) and 10% Owner in HISTOGENICS CORP ($HSGX) and 10% Owner in AquaBounty Technologies, Inc. ($AQB).
RANDAL J KIRK in SOLIGENIX, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: 10% Owner
Holdings: 583,334 shares
Latest Transaction: May 08 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RANDAL J KIRK in SOLIGENIX, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AQB, APHB, NOVI, FCSC, GYHT, HSGX, OGEN, XON, PRPO, SNGX, SYN, ZIOP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Option Exercise | X | 0.80 | 250,000 | 200,000 | 0 | |
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.54 | 1,881 | 4,778 | 85,397 | 87.3 K to 85.4 K (-2.16 %) |
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.70 | 13,893 | 37,511 | 87,278 | 101.2 K to 87.3 K (-13.73 %) |
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.97 | 2,278 | 6,766 | 101,171 | 103.4 K to 101.2 K (-2.20 %) |
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.54 | 9,695 | 24,625 | 440,418 | 450.1 K to 440.4 K (-2.15 %) |
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.70 | 71,607 | 193,339 | 450,113 | 521.7 K to 450.1 K (-13.73 %) |
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.97 | 11,739 | 34,865 | 521,720 | 533.5 K to 521.7 K (-2.20 %) |
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 4.01 | 49,875 | 199,999 | 533,459 | 583.3 K to 533.5 K (-8.55 %) |
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Buy | X | 0.80 | 250,000 | 200,000 | 583,334 | 333.3 K to 583.3 K (+75.00 %) |
Page: 1